Global Substance Abuse Treatment Market 2017-2021
- SKU ID : TNV-IRTNTR13568 10711462
- |
- Publishing Date: 14-Jun-2017
- |
- Region: Global
- |
- No. of pages: 73
About Substance Abuse Treatment
Substance abuse is defined as an illicit use of alcohol, drugs, or cigarettes. They are potentially addictive in nature, difficult to treat, and have a negative impact on body and overall health. The major factors driving the market is the increase in substance usage and the number of associated deaths. It is also identified as a high economic burden. Substance abuse is one of the primary causes of death globally and a major economic burden. Substance abuse, along with addiction is associated with a variety of chronic diseases.
Technavio’s analysts forecast the global substance abuse treatment market to grow at a CAGR of 5.15% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global substance abuse treatment market for 2017-2021. To calculate the market size, the report considers the sales from both generic and branded drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Substance Abuse Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alkermes
• Allergan
• GSK
• Pfizer
Other prominent vendors
• Accord Healthcare
• Amphastar Pharmaceuticals
• Apotex
• BioCorRx
• Cipla
• Glenmark
• INSYS Therapeutics
• LFB Group
• Lupin
• Mylan Laboratories
• Opiant Technologies
• Sanofi Aventis
• Sanquin
• Sterinova
• Sun Pharma
• Teva Pharmaceutical
Market driver
• Multiple facets of treatment
• For a full, detailed list, view our report
Market challenge
• High cost of treatment
• For a full, detailed list, view our report
Market trend
• Consolidation of rehabilitation centers
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Substance abuse is defined as an illicit use of alcohol, drugs, or cigarettes. They are potentially addictive in nature, difficult to treat, and have a negative impact on body and overall health. The major factors driving the market is the increase in substance usage and the number of associated deaths. It is also identified as a high economic burden. Substance abuse is one of the primary causes of death globally and a major economic burden. Substance abuse, along with addiction is associated with a variety of chronic diseases.
Technavio’s analysts forecast the global substance abuse treatment market to grow at a CAGR of 5.15% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global substance abuse treatment market for 2017-2021. To calculate the market size, the report considers the sales from both generic and branded drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Substance Abuse Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alkermes
• Allergan
• GSK
• Pfizer
Other prominent vendors
• Accord Healthcare
• Amphastar Pharmaceuticals
• Apotex
• BioCorRx
• Cipla
• Glenmark
• INSYS Therapeutics
• LFB Group
• Lupin
• Mylan Laboratories
• Opiant Technologies
• Sanofi Aventis
• Sanquin
• Sterinova
• Sun Pharma
• Teva Pharmaceutical
Market driver
• Multiple facets of treatment
• For a full, detailed list, view our report
Market challenge
• High cost of treatment
• For a full, detailed list, view our report
Market trend
• Consolidation of rehabilitation centers
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
